Home > > > > > Report Detail

Global Sickle-cell Anemia Therapeutics Market Size, Status and Forecast 2019-2025

Publisher Name :
Date: 15-Jul-2019
No. of pages: 99
Inquire Before Buying

Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).

In the last several years, global market of Sickle Cell Anemia Therapeutics developed rapidly, with an average growth rate of 13.32% during 2013 to 2017. In 2017, global revenue of Sickle Cell Anemia Therapeutics is nearly 1900 M USD.

In 2018, the global Sickle-cell Anemia Therapeutics market size was 1900 million US$ and it is expected to reach 5830 million US$ by the end of 2025, with a CAGR of 15.0% during 2019-2025.

This report focuses on the global Sickle-cell Anemia Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sickle-cell Anemia Therapeutics development in United States, Europe and China.

The key players covered in this study

- Addmedica

- Gamida Cell

- GlycoMimetics

- Pfizer

- Novartis

- Global Blood Therapeutics

- Micelle BioPharma

- Bluebird Bio

- Prolong Pharmaceuticals

- Modus Therapeutics

- Sangamo Biosciences

- Bioverativ

- Imara

- Ironwood Pharmaceuticals

Market segment by Type, the product can be split into

- Blood Transfusion

- Pharmacotherapy

- Bone Marrow Transplant

Market segment by Application, split into

- Child

- Adult

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Sickle-cell Anemia Therapeutics status, future forecast, growth opportunity, key market and key players.

- To present the Sickle-cell Anemia Therapeutics development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Sickle-cell Anemia Therapeutics are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Sickle-cell Anemia Therapeutics Market Size, Status and Forecast 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sickle-cell Anemia Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Blood Transfusion
1.4.3 Pharmacotherapy
1.4.4 Bone Marrow Transplant
1.5 Market by Application
1.5.1 Global Sickle-cell Anemia Therapeutics Market Share by Application (2014-2025)
1.5.2 Child
1.5.3 Adult
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Sickle-cell Anemia Therapeutics Market Size
2.2 Sickle-cell Anemia Therapeutics Growth Trends by Regions
2.2.1 Sickle-cell Anemia Therapeutics Market Size by Regions (2014-2025)
2.2.2 Sickle-cell Anemia Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Sickle-cell Anemia Therapeutics Market Size by Manufacturers
3.1.1 Global Sickle-cell Anemia Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Sickle-cell Anemia Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sickle-cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Sickle-cell Anemia Therapeutics Key Players Head office and Area Served
3.3 Key Players Sickle-cell Anemia Therapeutics Product/Solution/Service
3.4 Date of Enter into Sickle-cell Anemia Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Sickle-cell Anemia Therapeutics Market Size by Type (2014-2019)
4.2 Global Sickle-cell Anemia Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Sickle-cell Anemia Therapeutics Market Size (2014-2019)
5.2 Sickle-cell Anemia Therapeutics Key Players in United States
5.3 United States Sickle-cell Anemia Therapeutics Market Size by Type
5.4 United States Sickle-cell Anemia Therapeutics Market Size by Application
6 Europe
6.1 Europe Sickle-cell Anemia Therapeutics Market Size (2014-2019)
6.2 Sickle-cell Anemia Therapeutics Key Players in Europe
6.3 Europe Sickle-cell Anemia Therapeutics Market Size by Type
6.4 Europe Sickle-cell Anemia Therapeutics Market Size by Application
7 China
7.1 China Sickle-cell Anemia Therapeutics Market Size (2014-2019)
7.2 Sickle-cell Anemia Therapeutics Key Players in China
7.3 China Sickle-cell Anemia Therapeutics Market Size by Type
7.4 China Sickle-cell Anemia Therapeutics Market Size by Application
8 Japan
8.1 Japan Sickle-cell Anemia Therapeutics Market Size (2014-2019)
8.2 Sickle-cell Anemia Therapeutics Key Players in Japan
8.3 Japan Sickle-cell Anemia Therapeutics Market Size by Type
8.4 Japan Sickle-cell Anemia Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Sickle-cell Anemia Therapeutics Market Size (2014-2019)
9.2 Sickle-cell Anemia Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Sickle-cell Anemia Therapeutics Market Size by Type
9.4 Southeast Asia Sickle-cell Anemia Therapeutics Market Size by Application
10 India
10.1 India Sickle-cell Anemia Therapeutics Market Size (2014-2019)
10.2 Sickle-cell Anemia Therapeutics Key Players in India
10.3 India Sickle-cell Anemia Therapeutics Market Size by Type
10.4 India Sickle-cell Anemia Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Sickle-cell Anemia Therapeutics Market Size (2014-2019)
11.2 Sickle-cell Anemia Therapeutics Key Players in Central & South America
11.3 Central & South America Sickle-cell Anemia Therapeutics Market Size by Type
11.4 Central & South America Sickle-cell Anemia Therapeutics Market Size by Application
12 International Players Profiles
12.1 Addmedica
12.1.1 Addmedica Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sickle-cell Anemia Therapeutics Introduction
12.1.4 Addmedica Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)
12.1.5 Addmedica Recent Development
12.2 Gamida Cell
12.2.1 Gamida Cell Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sickle-cell Anemia Therapeutics Introduction
12.2.4 Gamida Cell Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)
12.2.5 Gamida Cell Recent Development
12.3 GlycoMimetics
12.3.1 GlycoMimetics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sickle-cell Anemia Therapeutics Introduction
12.3.4 GlycoMimetics Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)
12.3.5 GlycoMimetics Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sickle-cell Anemia Therapeutics Introduction
12.4.4 Pfizer Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sickle-cell Anemia Therapeutics Introduction
12.5.4 Novartis Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Global Blood Therapeutics
12.6.1 Global Blood Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sickle-cell Anemia Therapeutics Introduction
12.6.4 Global Blood Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)
12.6.5 Global Blood Therapeutics Recent Development
12.7 Micelle BioPharma
12.7.1 Micelle BioPharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sickle-cell Anemia Therapeutics Introduction
12.7.4 Micelle BioPharma Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)
12.7.5 Micelle BioPharma Recent Development
12.8 Bluebird Bio
12.8.1 Bluebird Bio Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sickle-cell Anemia Therapeutics Introduction
12.8.4 Bluebird Bio Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)
12.8.5 Bluebird Bio Recent Development
12.9 Prolong Pharmaceuticals
12.9.1 Prolong Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sickle-cell Anemia Therapeutics Introduction
12.9.4 Prolong Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)
12.9.5 Prolong Pharmaceuticals Recent Development
12.10 Modus Therapeutics
12.10.1 Modus Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Sickle-cell Anemia Therapeutics Introduction
12.10.4 Modus Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)
12.10.5 Modus Therapeutics Recent Development
12.11 Sangamo Biosciences
12.12 Bioverativ
12.13 Imara
12.14 Ironwood Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Sickle-cell Anemia Therapeutics Key Market Segments
Table Key Players Sickle-cell Anemia Therapeutics Covered
Table Global Sickle-cell Anemia Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Sickle-cell Anemia Therapeutics Market Size Market Share by Type 2014-2025
Figure Blood Transfusion Figures
Table Key Players of Blood Transfusion
Figure Pharmacotherapy Figures
Table Key Players of Pharmacotherapy
Figure Bone Marrow Transplant Figures
Table Key Players of Bone Marrow Transplant
Table Global Sickle-cell Anemia Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Child Case Studies
Figure Adult Case Studies
Figure Sickle-cell Anemia Therapeutics Report Years Considered
Table Global Sickle-cell Anemia Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Sickle-cell Anemia Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Sickle-cell Anemia Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Sickle-cell Anemia Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Sickle-cell Anemia Therapeutics Market Share by Regions 2014-2019
Figure Global Sickle-cell Anemia Therapeutics Market Share by Regions 2014-2019
Figure Global Sickle-cell Anemia Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Sickle-cell Anemia Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Sickle-cell Anemia Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Sickle-cell Anemia Therapeutics Market Share by Manufacturers in 2018
Table Global Sickle-cell Anemia Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Sickle-cell Anemia Therapeutics Product/Solution/Service
Table Date of Enter into Sickle-cell Anemia Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Sickle-cell Anemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Sickle-cell Anemia Therapeutics Market Size Share by Type (2014-2019)
Figure Global Sickle-cell Anemia Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Sickle-cell Anemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Sickle-cell Anemia Therapeutics Market Size Share by Application (2014-2019)
Figure Global Sickle-cell Anemia Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Sickle-cell Anemia Therapeutics Revenue Market Share by Application in 2018
Figure United States Sickle-cell Anemia Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Sickle-cell Anemia Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Sickle-cell Anemia Therapeutics Market Share (2018-2019)
Table United States Sickle-cell Anemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Sickle-cell Anemia Therapeutics Market Share by Type (2014-2019)
Table United States Sickle-cell Anemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Sickle-cell Anemia Therapeutics Market Share by Application (2014-2019)
Figure Europe Sickle-cell Anemia Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Sickle-cell Anemia Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Sickle-cell Anemia Therapeutics Market Share (2018-2019)
Table Europe Sickle-cell Anemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Sickle-cell Anemia Therapeutics Market Share by Type (2014-2019)
Table Europe Sickle-cell Anemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Sickle-cell Anemia Therapeutics Market Share by Application (2014-2019)
Figure China Sickle-cell Anemia Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Sickle-cell Anemia Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Sickle-cell Anemia Therapeutics Market Share (2018-2019)
Table China Sickle-cell Anemia Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Sickle-cell Anemia Therapeutics Market Share by Type (2014-2019)
Table China Sickle-cell Anemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Sickle-cell Anemia Therapeutics Market Share by Application (2014-2019)
Figure Japan Sickle-cell Anemia Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Sickle-cell Anemia Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Sickle-cell Anemia Therapeutics Market Share (2018-2019)
Table Japan Sickle-cell Anemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Sickle-cell Anemia Therapeutics Market Share by Type (2014-2019)
Table Japan Sickle-cell Anemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Sickle-cell Anemia Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Sickle-cell Anemia Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Sickle-cell Anemia Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Sickle-cell Anemia Therapeutics Market Share (2018-2019)
Table Southeast Asia Sickle-cell Anemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Sickle-cell Anemia Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Sickle-cell Anemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Sickle-cell Anemia Therapeutics Market Share by Application (2014-2019)
Figure India Sickle-cell Anemia Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Sickle-cell Anemia Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Sickle-cell Anemia Therapeutics Market Share (2018-2019)
Table India Sickle-cell Anemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Sickle-cell Anemia Therapeutics Market Share by Type (2014-2019)
Table India Sickle-cell Anemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Sickle-cell Anemia Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Sickle-cell Anemia Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Sickle-cell Anemia Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Sickle-cell Anemia Therapeutics Market Share (2018-2019)
Table Central & South America Sickle-cell Anemia Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Sickle-cell Anemia Therapeutics Market Share by Type (2014-2019)
Table Central & South America Sickle-cell Anemia Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Sickle-cell Anemia Therapeutics Market Share by Application (2014-2019)
Table Addmedica Company Details
Table Addmedica Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019) (Million US$)
Figure Addmedica Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2014-2019)
Table Addmedica Recent Development
Table Gamida Cell Company Details
Table Gamida Cell Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)(Million US$)
Figure Gamida Cell Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2014-2019)
Table Gamida Cell Recent Development
Table GlycoMimetics Company Details
Table GlycoMimetics Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)(Million US$)
Figure GlycoMimetics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2014-2019)
Table GlycoMimetics Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Global Blood Therapeutics Company Details
Table Global Blood Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)(Million US$)
Figure Global Blood Therapeutics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2014-2019)
Table Global Blood Therapeutics Recent Development
Table Micelle BioPharma Company Details
Table Micelle BioPharma Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)(Million US$)
Figure Micelle BioPharma Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2014-2019)
Table Micelle BioPharma Recent Development
Table Bluebird Bio Company Details
Table Bluebird Bio Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)(Million US$)
Figure Bluebird Bio Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2014-2019)
Table Bluebird Bio Recent Development
Table Prolong Pharmaceuticals Company Details
Table Prolong Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)(Million US$)
Figure Prolong Pharmaceuticals Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2014-2019)
Table Prolong Pharmaceuticals Recent Development
Table Modus Therapeutics Company Details
Table Modus Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2014-2019)(Million US$)
Figure Modus Therapeutics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2014-2019)
Table Modus Therapeutics Recent Development
Table Sangamo Biosciences Company Details
Table Bioverativ Company Details
Table Imara Company Details
Table Ironwood Pharmaceuticals Company Details
Table Global Sickle-cell Anemia Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Sickle-cell Anemia Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Sickle-cell Anemia Therapeutics Market Size Share by Regions in 2025
Figure United States Sickle-cell Anemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Sickle-cell Anemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Sickle-cell Anemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Sickle-cell Anemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Sickle-cell Anemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Sickle-cell Anemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Sickle-cell Anemia Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Sickle-cell Anemia Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Sickle-cell Anemia Therapeutics Market Size by Product (2019-2025)
Figure Global Sickle-cell Anemia Therapeutics Market Size by Product in 2025
Table Global Sickle-cell Anemia Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Sickle-cell Anemia Therapeutics Market Size by Application (2019-2025)
Figure Global Sickle-cell Anemia Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Fibrinogen Concentrate Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......
  • Global Fibrinogen Concentrate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91
    According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......
  • Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......
  • Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......
  • Global Low Molecular Weight Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......
  • Global Heparin Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......
  • Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......
  • Global Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs